Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Demisch

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Neurology|December 1, 1993
Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosisM Ott, L Demisch, W Engelhardt, et al.
Acta Neurologica Scandinavica|June 5, 1998
Glutamine synthetase activity in patients with Parkinson's diseaseF Zipp, L Demisch, A Derouiche, et al.
The American Journal of Psychiatry|November 1, 1983
Comparison of the ACTH suppression test and dexamethasone suppression test in depressed patientsK Demisch, L Demisch, H J Bochnik, et al.
Pharmacopsychiatry|November 1, 1988
The effect of OPC-4392, a partial dopamine receptor agonist on negative symptoms: results of an open studyH Gerbaldo, L Demisch, C O Lehmann, et al.
Journal of Pineal Research|January 1, 1989
Influence of subchronic intake of melatonin at various times of the day on fatigue and hormonal levels: a placebo-controlled, double-blind trialT Nickelsen, L Demisch, K Demisch, et al.
British Journal of Clinical Pharmacology|January 1, 1995
Concentration-effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulationS Harder, H Baas, N Bergemann, et al.
Pharmacopsychiatry|November 1, 1987
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depressionA Steiger, F Holsboer, A Gerken, et al.
Psychiatry Research|June 1, 1982
Correlation of platelet MAO activity with introversion: a study on a German rural populationL Demisch, K Georgi, B Patzke, et al.
Psychiatry Research|December 1, 1987
Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophreniform or schizophrenic disordersL Demisch, H Gerbaldo, P Gebhart, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Case report: treatment of a patient with sleep phase advance disorder with phototherapy]U Voderholzer, A Wirz-Justice, L Demisch, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Neurology|December 1, 1993
Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosisM Ott, L Demisch, W Engelhardt, et al.
Acta Neurologica Scandinavica|June 5, 1998
Glutamine synthetase activity in patients with Parkinson's diseaseF Zipp, L Demisch, A Derouiche, et al.
The American Journal of Psychiatry|November 1, 1983
Comparison of the ACTH suppression test and dexamethasone suppression test in depressed patientsK Demisch, L Demisch, H J Bochnik, et al.
Pharmacopsychiatry|November 1, 1988
The effect of OPC-4392, a partial dopamine receptor agonist on negative symptoms: results of an open studyH Gerbaldo, L Demisch, C O Lehmann, et al.
Journal of Pineal Research|January 1, 1989
Influence of subchronic intake of melatonin at various times of the day on fatigue and hormonal levels: a placebo-controlled, double-blind trialT Nickelsen, L Demisch, K Demisch, et al.
British Journal of Clinical Pharmacology|January 1, 1995
Concentration-effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulationS Harder, H Baas, N Bergemann, et al.
Pharmacopsychiatry|November 1, 1987
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depressionA Steiger, F Holsboer, A Gerken, et al.
Psychiatry Research|June 1, 1982
Correlation of platelet MAO activity with introversion: a study on a German rural populationL Demisch, K Georgi, B Patzke, et al.
Psychiatry Research|December 1, 1987
Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophreniform or schizophrenic disordersL Demisch, H Gerbaldo, P Gebhart, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Case report: treatment of a patient with sleep phase advance disorder with phototherapy]U Voderholzer, A Wirz-Justice, L Demisch, et al.
Pageof 6